Geneos Wealth Management’s iShares Core Moderate Allocation ETF AOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$198K Buy
4,190
+1,821
+77% +$87.8K ﹤0.01% 958
2025
Q4
$113K Sell
2,369
-16
-0.7% -$765 ﹤0.01% 1112
2025
Q3
$113K Buy
2,385
+1,148
+93% +$53.4K ﹤0.01% 1078
2025
Q2
$57K Sell
1,237
-443
-26% -$19.6K ﹤0.01% 1499
2025
Q1
$73.7K Buy
1,680
+346
+26% +$15.2K ﹤0.01% 1722
2024
Q4
$57.9K Hold
1,334
﹤0.01% 1260
2024
Q3
$60.2K Buy
1,334
+354
+36% +$15.5K ﹤0.01% 1134
2024
Q2
$42.1K Sell
980
-194
-17% -$8.22K ﹤0.01% 1122
2024
Q1
$50.2K Sell
1,174
-72
-6% -$3.01K ﹤0.01% 1063
2023
Q4
$51.7K Hold
1,246
﹤0.01% 1049
2023
Q3
$48.5K Buy
1,246
+740
+146% +$29.6K ﹤0.01% 1086
2023
Q2
$20.4K Sell
506
-1,321
-72% -$52.7K ﹤0.01% 1372
2023
Q1
$72.8K Sell
1,827
-1,153
-39% -$45.3K ﹤0.01% 947
2022
Q4
$113K Sell
2,980
-500
-14% -$19K 0.01% 796
2022
Q3
$127K Sell
3,480
-16,969
-83% -$665K 0.01% 729
2022
Q2
$802K Sell
20,449
-1,866
-8% -$75.4K 0.04% 380
2022
Q1
$958K Sell
22,315
-93,435
-81% -$4.07M 0.04% 370
2021
Q4
$5.26M Buy
115,750
+2,666
+2% +$121K 0.2% 112
2021
Q3
$5.07M Buy
113,084
+991
+0.9% +$44.9K 0.19% 123
2021
Q2
$5.05M Sell
112,093
-5,862
-5% -$261K 0.2% 121
2021
Q1
$5.25M Buy
117,955
+1,803
+2% +$78.5K 0.15% 164
2020
Q4
$4.78M Buy
116,152
+14,219
+14% +$599K 0.19% 129
2020
Q3
$4.16M Buy
101,933
+6,817
+7% +$279K 0.22% 106
2020
Q2
$3.77M Buy
95,116
+2,355
+3% +$90.9K 0.21% 112
2020
Q1
$3.38M Buy
92,761
+1,359
+1% +$53.2K 0.23% 104
2019
Q4
$3.67M Buy
91,402
+4,898
+6% +$194K 0.2% 130
2019
Q3
$3.39M Sell
86,504
-203
-0.2% -$7.91K 0.2% 124
2019
Q2
$3.38M Buy
86,707
+3,594
+4% +$138K 0.21% 120
2019
Q1
$3.16M Sell
83,113
-280
-0.3% -$10.4K 0.21% 132
2018
Q4
$2.97M Buy
83,393
+2,042
+3% +$74.5K 0.22% 124
2018
Q3
$3.08M Buy
81,351
+4,894
+6% +$185K 0.21% 139
2018
Q2
$2.87M Buy
76,457
+6,392
+9% +$240K 0.22% 117
2018
Q1
$2.65M Buy
70,065
+4,742
+7% +$181K 0.23% 113
2017
Q4
$2.5M Buy
65,323
+7,852
+14% +$301K 0.22% 116
2017
Q3
$2.18M Buy
57,471
+49,345
+607% +$1.85M 0.22% 119
2017
Q2
$302K Buy
8,126
+1,335
+20% +$49.3K 0.03% 394
2017
Q1
$246K Buy
6,791
+35
+0.5% +$1.26K 0.03% 427
2016
Q4
$238K Buy
6,756
+474
+8% +$16.8K 0.03% 420
2016
Q3
$226K Buy
6,282
+1,528
+32% +$54.7K 0.03% 416
2016
Q2
$168K Buy
4,754
+150
+3% +$5.24K 0.02% 479
2016
Q1
$160K Buy
+4,604
New +$155K 0.02% 476

Other funds holding AOM

Geneos Wealth Management's AOM Position: Q1 2026 in Review

Geneos Wealth Management increased its iShares Core Moderate Allocation ETF (AOM) stake by 77% in Q1 2026, buying an estimated $87.8K and bringing the position to 4,190 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #958.

Geneos Wealth Management first reported a position in AOM in Q1 2016 and has held it in 41 quarters since. The position peaked at $5.26M in Q4 2021. 292 funds tracked by Wall St. Rank hold AOM as of Q1 2026.

  • Geneos Wealth Management held 4,190 shares of iShares Core Moderate Allocation ETF worth $198K as of Q1 2026.
  • Geneos Wealth Management bought 1,821 iShares Core Moderate Allocation ETF shares in Q1 2026, an estimated $87.8K.
  • iShares Core Moderate Allocation ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #958 holding.
  • Geneos Wealth Management first reported a position in iShares Core Moderate Allocation ETF in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's iShares Core Moderate Allocation ETF position peaked at $5.26M in Q4 2021.
  • 292 funds tracked by Wall St. Rank held iShares Core Moderate Allocation ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.